FDA approves Novavax COVID vaccine grown in moth cells — 100% efficacy claim based on just 14 placebo cases, raising serious safety concerns

(NaturalNews) While the mainstream media touts Novavax’s Nuvaxovid as a “safer, more traditional” alternative to mRNA vaccines, the truth behind its FDA approval …